Cardiovascular Death and Testosterone
If you listen to most docs who are unfamiliar with
TRT, they steer men away from testosterone because somewhere in their training
they were told that testosterone leads to heart attacks. To their credit, if what they were told was
true, that would be the right thing to do. But is it? Is the information they
were spoon-fed correct?
Up until 2015, there was no study that looked at Testosterone Replacement Therapy Orange County (TRT) and cardiovascular death rates. Fortunately, Sharma et al.,
did a study with 83,010 veterans on TRT and looked at cardiovascular outcomes
including heart attacks and strokes. The aim of the study was to look at what
happened to outcomes when testosterone (T) levels were normalized.
The veterans were broken into three groups, one
received no treatment, one received treatment off/on (no normalization of T
levels), and the other group received TRT with normalization of T levels. The
median age of participants was 66 years and time of follow-up was 6.2 years.
The end data showed that the group who had
testosterone levels normalized were 56% less likely to die from all causes
compared to the non-treatment group. They were 36% less likely to have a stroke
and 24% less likely to have a heart attack.
There was no difference in heart attacks and stroke rates among the
partial treatment group and the non-treatment group.
Comments
Post a Comment